Osteochondral Defect
📧 Sign up to get email alerts when something new happens for Osteochondral Defect.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Evaluating Cryopreserved Osteochondral Allograft Cores for the Treatment of Osteochondral Lesions in the Knee [NA]
This entry reports a recruiting clinical trial evaluating cryopreserved osteochondral allograft cores for osteochondral defects in the knee.…
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: Clinical Registry Assessment of the Missouri Osteochondral Allograft Preservation System - MOPS
ClinicalTrials.gov registry entry for the Missouri Osteochondral Allograft Preservation System (MOPS) study, noting that enrollment is ongoi…
-
CLINICAL_TRIALS other · 2025-03-26Clinical Trial Update: EB-OC for the Treatment of Focal Chondral/Osteochondral Defects in the Knee [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/Phase 2 study of EB-OC for focal chondral/osteochondral defects in the knee, with status not yet …
-
CLINICAL_TRIALS trial_result · 2019-02-11Clinical Trial Update: Post-Operative Rehabilitation of Knee Osteochondral Defect: A Case Series
This document reports a completed case-series on post-operative rehabilitation for knee osteochondral defects. It summarizes recovery outcom…
-
EMA withdrawal · 2018-07-05EMA Expired: Maci (autologous cultured chondrocytes) — Vericel Denmark ApS
The EMA has expired the Maci (autologous cultured chondrocytes) product license from Vericel Denmark ApS, affecting its use for fractures an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2009-05-01Clinical Trial Update: The Use of Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Articular Cartilage Defects [Phase 2, Phase 3]
Update on a trial using autologous bone marrow mesenchymal stem cells to treat articular cartilage defects. The study is listed as Phase 2 a…